Google Biogen Seek Reasons for Advance of Multiple Sclerosis
Jan 27, 2015, 00:00 AM
by
Michael Croft
Bloomberg | Google Inc., expanding its foray into
medical research, will join multiple sclerosis drugmaker Biogen
Idec Inc. to study environmental and biological contributors to the
debilitating disease's progression.
January 27, 2015 | Google Inc., expanding its foray into medical research, will join multiple sclerosis drugmaker Biogen Idec Inc. to study environmental and biological contributors to the debilitating disease's progression. Bloomberg